Intensity-Modulated Radiation Charges for Prostate Cancer Vary
Mean charge for standard 28-fraction was $111,728.80, 10.1 times the price paid by Medicare.
Radiotherapy
Prostate Cancer Treatment Side Effects Worse With Prostatectomy
In a study, localized prostate cancer patients reported clinically meaningful differences in urinary, bowel, sexual, and hormonal function by management option up to 5 years of follow-up.
Adding Chemo to Radiation Treatment for MIBC Does Not Worsen HRQoL
Findings from a large study of bladder-sparing treatments for muscle-invasive bladder cancer support the routine use of 5-fluorouracil and mitomycin C concomitantly with radiation therapy.
Whole Pelvis Radiotherapy for High-Risk Prostate Cancer May Improve Outcomes
Whole pelvis radiotherapy (WPRT) may improve treatment outcomes among patients with intermediate- or high-risk prostate cancer compared with prostate-only radiotherapy (PORT), a new study suggests. A team led by Peter J. Hoskin, MD, PhD, of Southampton General Hospital in Southampton, UK, compared the approaches in a prospective cohort study that included 812 men with intermediate-…
SBRT Shortens Tx for Prostate Cancer Without Greater Toxicity
Ultra-hypofractionated stereotactic body radiotherapy cuts treatment from 2 months to 2 weeks
Radiation Therapy After Prostate Surgery Offers No Benefit
Study findings suggest that many men can be spared radiation therapy following radical prostatectomy for high-risk prostate cancer.
Re-Treatment With Radium-223 Appears Safe
In a study, select CRPC patients who benefited from initial radium‐223 therapy but later had bone progression were re-challenged with additional radium-223 injections and had no serious adverse effects.
Docetaxel Following Prostate Cancer Radiotherapy Not Beneficial
Adjuvant docetaxel given to men who underwent radiotherapy for intermediate- or high-risk prostate cancer and who were on androgen deprivation therapy did not lower their risk of PSA progression, a study found.
Men With High-Risk PCa and Low PSA May Benefit More From Surgery Than Radiation
In a study, radical prostatectomy for men with Gleason 8-10 prostate cancer and low PSA levels was associated with a lower death risk compared with external beam radiation therapy with or without brachytherapy.
Study Supports Ultra-Hypofractionated Radiotherapy for Prostate Cancer
Ultra-hypofractionated and conventionally fractionated radiotherapy for intermediate- or high-risk prostate cancer are associated with similar 5-year failure-free survival rates, a randomized phase 3 trial found.
Next post in Prostate Cancer
